This week, we will discuss the clinical significance of eGFRdiff, the difference in eGFRcys (cystatin C) and eGFRcr (creatinine).
A dose of CONFIDENCE: Building evidence for finerenone-empagliflozin synergy in diabetic kidney disease
From single shots to strategy: How CAPTIVATE is reframing the NephTrials playbook
Are E-Nudges Enough to Push Guideline-Based CKD Therapy?
STAMP of Approval: Tacrolimus vs MMF in Pediatric Nephrotic Syndrome
Advance-HTN: Return of the systolic order – Lorundrostat’s role in restoring balance
Double Trouble: ddAVP and the Bleeding Biopsy
Kidney Allografts-Play With Fire, Get Burned
Metformin- Should I Stay or Should I Go
KDIGO 2025 ADPKD Guidelines Review
This week, we will discuss the first iteration of KDIGO’s 2025 guidelines on ADPKD. These guidelines are a result of a decade of global collaboration between physicians, researchers, advocates, and patients. The guidelines incorporate ADPKD-specific care as well as many general CKD management practice points.